In contrast, although CPZ exhibited some antileukemic activities on AML cells with FLT3 WT/KIT WT (Fig. 6c), a statistically significant effect was observed in only one case (case #17) out of ten analyzed samples. The gene discussed is KIT; the disease is acute myeloid leukemia.